| Date Filed | Type | Description |
| 01/30/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 01/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/19/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 01/19/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/19/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/19/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/19/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/19/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/19/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/19/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/19/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/19/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/19/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/19/2023 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 01/18/2023 |
8-K
| Quarterly results |
| 01/05/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 01/03/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/23/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/20/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/02/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/02/2022 |
8-K
| Quarterly results |
| 11/25/2022 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 11/15/2022 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 11/07/2022 |
8-K
| Quarterly results |
| 11/07/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/01/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/20/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/18/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/18/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/18/2022 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agreement and Plan of Merger, by and among AVEO Pharmaceuticals, Inc., LG Chem, Ltd. and Acacia Acquisition Sub, Inc",
"Second Amended and Restated Bylaws of AVEO Pharmaceuticals, Inc., as amended",
"LG Chem to Acquire AVEO Oncology for $15.00 Per Share in Cash" |
|
| 08/09/2022 |
8-K
| Investor presentation |
| 08/04/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
|